Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
From sharesmagazine:
---
HOME TEST KIT
Separately, Omega Diagnostics announced on 9 April it will become part of the UK Rapid Test Consortium to jointly develop and manufacture a COVID-19 antibody test.
Omega’s test kits look similar to pregnancy testing strips but a blood sample is required in place of urine.
The antibody test will allow individuals who were previously ill with the virus, but never tested, to potentially go back to work with the knowledge they have built up immunity.
---
When can we expect the home version to be ready? That day will be big
Raptor,
There are videos discussing Phase III results with some data: https://www.futuramedical.com/investor-centre/videos-and-webcasts/videos/
Also it is possible to find some information with the study number like the following https://www.smartpatients.com/trials/NCT03813992
It seems to me that this share will shoot up days before the prototype presentation (10 days or soI would think), then probably more upside again when it's presented, then another 2 weeks for the 1.0 milestone... then no idea after that. It would depend on whether they actually get clients for their product
those wicks happen sometimes, it was quickly bought and bounced back which often indicates a trend reversal (going up from there). Let's see, I'm waiting for next RNS with sales updates more than worried at analysing the price action
it was 99.9% ran past a patent attorney (or most likely an specialised firm). FUM has a few patents granted in the past so they know how to proceed
I'm just doing my research on this share, spreading the word and giving the consortium time will make this one multiply its market cap several times
In my experience you don't need to know how something works to get a patent, you just need to cover as many bases as you can. Intellectual Property Agencies are not scientific board carrying out experiments. I have come across and battled patents written without any implementation behind them (again, my area is hardware), their studies of efficacy beating a placebo would, I assume, help convince the patent examiners there's industrial value worth patenting here. What FUM is probably trying to protect is the molecule and formulations they have developed to avoid somebody else's benefiting from their R+D efforts
https://www.medrxiv.org/content/10.1101/2020.03.21.20037267v2
https://www.express.co.uk/life-style/health/1261359/coronavirus-cases-update-china-study-sexual-hormones-erectile-dysfunction
Some early studies and anecdotal evidence, (also a thing for the old SARS) suggest some survivors get a nasty long term reduction in testosterone productions, meaning worse erections meaning a bigger market for ED products
>>FrankM, thank you for a sensible response. So in your opinion do you think FUM will need to know the mode of action for how MED3000 to get the patent
No, they are most likely applying not for a mode of action but a formulation (and possibly molecule) given the title of the document is "Topical composition". The IPO (the intellectual property office) is not a scientific laboratory and won't carry out any peer review, examiners will just try to see if the patent scope is well define, if if clashes with existing prior art (patents, papers, etc) or not, if it adheres to legal standards (patent language has to be very precise). The examiner might ask for more clarification about the mechanisms of action though. FUM is hopefully verifying she science behind it independently of the patent application outcome
I have some experience with patents but in different areas (hardware), patents are filed as early as possible as that will give you/any company a priority date, then you have a deadline to submit the full document, this gives the applicant time to refine the document, polish details, etc. Then, after a rather long time (it depends on many factors but won't be less than months) the patent is published publicly, this stage hasn't been reached yet for FUM's patent.
Until that happens, we can only speculate about the content, only thing we know so far is the priority date claimed and the title of the patent application. When it becomes published we'll be able to read it, after it's published, there will be examiner searches, reports, substantive examinations, etc before it's granted.
Now we have the attack of the clones, 3 different profiles for the same person. Amazing. So much effort to try to deramp is a good sign!
Trinity Delta view: The analysis of the FM57 data shows a remarkably consistent outcomes across all treatment groups and supports the view that MED3000 is an effective and safe therapy for ED. Regulatory submissions for approval of MED3000 as a medical device opens a potentially faster route to market, with probably no further clinical work required for Europe and (possibly) a small study for the US. Although difficult to compare without direct trials, the efficacy seen would suggest an activity approaching that of oral PDE5s such as tadalafil (Cialis), but with a faster onset of action and fewer side-effects. As we highlighted previously, significant unknowns remain, but the outlook is increasingly positive. We suspended our forecasts and valuation at the time of the top line FM57 results and aim to reinstate them as soon as practicable.
https://www.trinitydelta.org/research-notes/med3000-more-detail-on-fm57-results/
I have posted the patent application several times, there's a patent application but those things take time, so far, it is on track
Enmity to FUM's board, in his case it must be personal and driven by emotions. There's no rational explanation to his behaviour.
I'm looking forward to TPR even more so than DermaSys, with social distancing going to last for months, consumer habits will change, physiotherapy clinics are closed at the moment and might have to take fewer or no patients for the months to come. Pain relief creams are going to be life saver for those patients.
I have just read Spain bought 5.5 million test kits from Chinese, from a shady biotech there... Tests that DON'T work. So they'll have to buy more tests, this time from Novacyt I hope, as Novacyt's are the most reliable on the market. Politicians only learn the hard way.
link in Spanish https://www.elindependiente.com/politica/2020/03/26/china-asegura-que-espana-compro-los-test-fallidos-a-una-empresa-sin-licencia/
This article in Spanish states that Spanish scientist (SEIMC , an official institution) have concluded quick Chinese tests are < 30% accurate, which is unacceptable
https://www.20minutos.es/noticia/4205543/0/informe-test-rapido-coronavirus-seimc-espana/
Novacyt announcing an antibodies test is not out of the realm of possibilities, I'm sure the board has at least discussed it.
On the other hand, I don't think this will hit £2 until strong sales figures are announced in the next RNS.